Streetbeat News

Stock Prices

TSLA

Gary Black from The Future Fund LLC highlights the similarities between Tesla's stock performance in 2019 and 2024, suggesting a potential price surge in 2025 with the launch of new affordable models. He warns short sellers that the new models will expand Tesla's market, similar to the Model Y's success.

Portfolio Pulse from Anan Ashraf

September 21, 2024 | 2:55 am

OTRK

Trading for OTRK has been halted as of 7:50:00 p.m. ET due to pending news. This indicates that significant information regarding the company is expected to be released soon.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 11:50 pm

RSLS

Trading for RSLS has been halted as of 7:50:00 p.m. ET due to pending news. This could indicate significant upcoming announcements that may impact the stock price.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 11:50 pm

TRAW

Trading for an unspecified asset was halted at 7:50:00 p.m. ET due to pending news. The halt indicates that significant information is expected to be released, which could impact the asset's price once trading resumes.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 11:50 pm

ORCL

Oracle (NYSE:ORCL) has outperformed the market over the past 5 years with an average annual return of 25.79%, significantly boosting investor returns. A $1000 investment in Oracle 5 years ago would now be worth $3,109.96.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 9:30 pm

ADMA

Analysts have provided mixed ratings for ADMA Biologics, with a recent increase in the average 12-month price target to $18.25. The company shows strong financial health with significant revenue growth and profitability metrics exceeding industry averages.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 9:01 pm

RNST

In the past three months, 10 analysts have rated Renasant (NYSE:RNST), with most being indifferent. The average 12-month price target has increased to $36.9, with a high of $41.00 and a low of $32.00. Analysts have adjusted their ratings and price targets, reflecting changing market conditions and company performance. Renasant shows strong financial health with a high net margin and ROE, but its revenue growth lags behind industry peers.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 9:01 pm

CATY

Cathay General (NASDAQ:CATY) has been analyzed by four analysts, showing a range of perspectives from somewhat bullish to somewhat bearish. The average 12-month price target has increased by 11.95% to $44.5. Despite a revenue decline of 12.76%, Cathay General maintains a strong net margin and effective asset utilization.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 9:01 pm

LOB

Analysts have mixed views on Live Oak Bancshares (NYSE:LOB) with recent ratings showing a shift towards bullish sentiment. The average 12-month price target has increased by 13.15% to $47.33. The company shows strong financial health with a positive revenue trend and efficient cost management.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 9:00 pm

RF

Analysts have varied opinions on Regions Financial (NYSE:RF), with recent ratings showing a mix of bullish and indifferent sentiments. The average 12-month price target has increased to $23.67, with a high of $28.00 and a low of $21.00. Despite revenue challenges, Regions Financial shows strong profitability and financial health.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 9:00 pm